相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance
Olena Masui et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
Alexander V. Vlassov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer
Hardev Pandha et al.
BJU INTERNATIONAL (2012)
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria
Funso Abogunrin et al.
CANCER (2012)
Statistical Methods for Test and Biomarker Evaluation Studies: A Clinical Chemistry Series
James C. Boyd et al.
CLINICAL CHEMISTRY (2012)
Commercial Immunoassays in Biomarkers Studies: Researchers Beware!
Nader Rifai et al.
CLINICAL CHEMISTRY (2012)
Established and Emerging Markers of Kidney Function
Michael A. Ferguson et al.
CLINICAL CHEMISTRY (2012)
Quantifying the Accuracy of a Diagnostic Test or Marker
Kristian Linnet et al.
CLINICAL CHEMISTRY (2012)
Quantifying the Added Value of a Diagnostic Test or Marker
Karel G. M. Moons et al.
CLINICAL CHEMISTRY (2012)
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: Application to RCC urinary exosomes
Piero Del Boccio et al.
ELECTROPHORESIS (2012)
Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany
Eric Schiffer et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
Identification of Prostate-Enriched Proteins by In-depth Proteomic Analyses of Expressed Prostatic Secretions in Urine
Simona Principe et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers
Yi-Ting Chen et al.
JOURNAL OF PROTEOMICS (2012)
Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness
Jerome Zoidakis et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer
Marten Linden et al.
PROTEOMICS (2012)
Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT)
Zhen Wang et al.
PROTEOMICS (2012)
Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics
Ruth Huttenhain et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Novel agents in renal carcinoma: a reality check
Yana G. Najjar et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma
Jeremiah J. Morrissey et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: A review
R. Bakry et al.
ANALYTICA CHIMICA ACTA (2011)
14-3-3 Protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid
Satoru Minamida et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis
Ming-Hui Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection Using LC/MS-MS and Label-Free Quantification
Na Yang et al.
CLINICAL CANCER RESEARCH (2011)
Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer
Richard Morgan et al.
CLINICAL CANCER RESEARCH (2011)
The Journey to Regulation of Protein-Based Multiplex Quantitative Assays
Emily S. Boja et al.
CLINICAL CHEMISTRY (2011)
Molecular Alterations during Progression of Prostate Cancer to Androgen Independence
Punit Saraon et al.
CLINICAL CHEMISTRY (2011)
Health Care Spending, Social Policy, Public Health, and Life Expectancy: What Cancer Outcomes Can Tell Us Beyond Treatment Efficacy
James W. F. Catto
EUROPEAN UROLOGY (2011)
Basic Research in Kidney Cancer
Egbert Oosterwijk et al.
EUROPEAN UROLOGY (2011)
Quantitative Analysis of the Intra- and Inter-Individual Variability of the Normal Urinary Proteome
Nagarjuna Nagaraj et al.
JOURNAL OF PROTEOME RESEARCH (2011)
A Comprehensive Map of the Human Urinary Proteome
Arivusudar Marimuthu et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Analysis of the variability of human normal urine by 2D-GE reveals a public and a private proteome
Laurence Molina et al.
JOURNAL OF PROTEOMICS (2011)
Regulatory perspective on translating proteomic biomarkers to clinical diagnostics
Jinong Li et al.
JOURNAL OF PROTEOMICS (2011)
A Tool for Biomarker Discovery in the Urinary Proteome: A Manually Curated Human and Animal Urine Protein Biomarker Database
Chen Shao et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Mapping intact protein isoforms in discovery mode using top-down proteomics
John C. Tran et al.
NATURE (2011)
Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma
Hongjie Li et al.
PROTEOME SCIENCE (2011)
Systematic quantification of peptides/proteins in urine using selected reaction monitoring
Nathalie Selevsek et al.
PROTEOMICS (2011)
Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer
Richard T. Bryan et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling
Hong-Lin Cheng et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
14-3-3 proteins as signaling integration points for cell cycle control and apoptosis
Alexandra K. Gardino et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
S. L. Wood et al.
BRITISH JOURNAL OF CANCER (2010)
Protein-Based Multiplex Assays: Mock Presubmissions to the US Food and Drug Administration
Fred E. Regnier et al.
CLINICAL CHEMISTRY (2010)
The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification
Shalini Makawita et al.
CLINICAL CHEMISTRY (2010)
Quantitative Clinical Proteomics by Liquid Chromatography-Tandem Mass Spectrometry: Assessing the Platform
Andrew N. Hoofnagle
CLINICAL CHEMISTRY (2010)
A Recipe for Proteomics Diagnostic Test Development: The OVA1 Test, from Biomarker Discovery to FDA Clearance
Eric T. Fung
CLINICAL CHEMISTRY (2010)
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
G. Mowatt et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology
Yi-Ting Chen et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
Jyothi Subramanian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Randomized Clinical Trials With Biomarkers: Design Issues
Boris Freidlin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Bikunin Loss in Urine as Useful Marker for Bladder Carcinoma
Ke-Hung Tsui et al.
JOURNAL OF UROLOGY (2010)
CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker
Lawrence D. True et al.
MODERN PATHOLOGY (2010)
Proteomics Analysis of Bladder Cancer Exosomes
Joanne L. Welton et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Urine biomarkers in prostate cancer
Guillaume Ploussard et al.
NATURE REVIEWS UROLOGY (2010)
Molecular screening for bladder cancer: progress and potential
Anirban P. Mitra et al.
NATURE REVIEWS UROLOGY (2010)
Urinary Biomarkers for the Early Diagnosis of Kidney Cancer
Jeremiah J. Morrissey et al.
MAYO CLINIC PROCEEDINGS (2010)
Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling?
Jennifer L. Merrimen et al.
PATHOLOGY (2010)
Taking a new biomarker into routine use - A perspective from the routine clinical biochemistry laboratory
Catharine Sturgeon et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Banking of clinical samples for proteomic biomarker studies: A consideration of logistical issues with a focus on pre-analytical variation
David H. Jackson et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Molecular pathways of urothelial development and bladder tumorigenesis
Mireia Castillo-Martin et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis
Lia-Beng Tan et al.
WORLD JOURNAL OF UROLOGY (2010)
Genoproteomic Mining of Urothelial Cancer Suggests γ-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
Courtney Pollard et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma
N. S. Vasudev et al.
BRITISH JOURNAL OF CANCER (2009)
Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
Eric Schiffer et al.
CLINICAL CANCER RESEARCH (2009)
Grade and Stage at Presentation Do Not Predict Mortality in Patients With Bladder Cancer Who Survive Their Disease
Edward M. Messing et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Proteomic Analysis of Human Parotid Gland Exosomes by Multidimensional Protein Identification Technology (MudPIT)
Mireya Gonzalez-Begne et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease
Justyna Jantos-Siwy et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease
Richard R. Drake et al.
JOURNAL OF PROTEOMICS (2009)
Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection
Martin Schostak et al.
JOURNAL OF UROLOGY (2009)
Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts
Sanshiro Okamoto et al.
ONCOLOGY REPORTS (2009)
Urine proteomics for profiling of human disease using high accuracy mass spectrometry
Alex Kentsis et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Benefits and harms of prostate-specific antigen screening for prostate cancer: An evidence update for the US preventive services task force
Kenneth Lin et al.
ANNALS OF INTERNAL MEDICINE (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Senescence-associated exosome release from human prostate cancer cells
Brian D. Lehmann et al.
CANCER RESEARCH (2008)
Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer
Hiroaki Kawanishi et al.
CLINICAL CANCER RESEARCH (2008)
Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
Steven A. Carr et al.
CLINICAL CHEMISTRY (2008)
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt
Nicco Bosso et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Discovery and validation of urinary biomarkers for propstate cancer
Dan Theodorescu et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Kidney Injury Molecule-1 (KIM-1): A specific and sensitive biomarker of kidney injury
Joseph V. Bonventre
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern
Deng-Long Wu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Use of urinary biomarkers for bladder cancer surveillance: Patient perspectives
Ofer Yossepowitch et al.
JOURNAL OF UROLOGY (2007)
Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urine
Amosy E. M'Koma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Urinary biomarker profiling in transitional cell carcinoma
Nicholas P. Munro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Searching cell-secreted proteomes for potential urinary bladder tumor markers
Chiao-Yun Lin et al.
PROTEOMICS (2006)
Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery
H Zhou et al.
KIDNEY INTERNATIONAL (2006)
Discovery and validation of new protein biomarkers for 4 urothelial cancer: a prospective analysis
D Theodorescu et al.
LANCET ONCOLOGY (2006)
The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins
Jun Adachi et al.
GENOME BIOLOGY (2006)
Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype
RD Loberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers
M Saito et al.
EUROPEAN UROLOGY (2005)
Exploring the hidden human urinary proteome via ligand library beads
A Castagna et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine
D Theodorescu et al.
ELECTROPHORESIS (2005)
Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis
JS Hwa et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Urinary-peptide excretion by patients with and volunteers without diabetes
KJ Strong et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2005)
Immunohistochemical expression of 14-3-3 sigma protein in human urological and gynecological tumors using a multi-tumor microarray analysis
P Mhawech et al.
PATHOLOGY INTERNATIONAL (2005)
Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma
K Kaya et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2005)
Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots
R Pieper et al.
PROTEOMICS (2004)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient
YF Zhang et al.
CLINICAL BIOCHEMISTRY (2004)
Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis
H Iwaki et al.
CANCER SCIENCE (2004)
Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes
EM Weissinger et al.
KIDNEY INTERNATIONAL (2004)
Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients
J Závada et al.
BRITISH JOURNAL OF CANCER (2003)
Prostate-specific antigen cutoff of 2.6 ng/ml for prostate cancer screening is associated with favorable pathologic tumor features
JS Krumholtz et al.
UROLOGY (2002)
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
A Vlahou et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
